Literature DB >> 2026423

A marked drop in the incidence of the null allele of the B gene of the fourth component of complement (C4B*Q0) in elderly subjects: C4B*Q0 as a probable negative selection factor for survival.

J Kramer1, T Fülöp, K Rajczy, A T Nguyen, G Füst.   

Abstract

The incidence of allotypes of the genes of the fourth component (C4) and factor B of the complement system was compared in 252 persons under 45 years of age ("young" group) with 482 people between 61 and 90 years of age ("old" group). One hundred people older than 90 years of age (nonagenarians) were also investigated. A striking difference was found between the "young" and "old" groups in the incidence (16.1% and 5.4%, respectively) of a silent gene of the C4B allele (C4B*Q0). This difference was even more marked among "young" and "old" men (17.6% vs 3.4%). The incidence of the C4B*Q0 allele in women dropped to the level of the men only in the nonagenarian group. The most probable explanation for this finding is that people carrying the C4B*Q0 allele die from as yet unidentified disease(s) in their middle-age. Therefore, male (and to a lesser extent female) carriers of this allele may have a considerably shorter life expectancy than individuals without a silent gene in the C4B locus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026423     DOI: 10.1007/bf00201547

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  Usefulness of densitometry in typing of human complement component C4.

Authors:  J Kramer; E Gyódi; G Füst
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Rapid determination of the human complement factor B phenotypes.

Authors:  J Kramer; E Thiry; G Füst
Journal:  Haematologia (Budap)       Date:  1989

3.  Low incidence of null alleles of the fourth component of complement (C4) in elderly people.

Authors:  J Kramer; K Rajczy; G Füst
Journal:  Immunol Lett       Date:  1989-01-15       Impact factor: 3.685

4.  Influence of major histocompatibility complex region genes on human longevity among Okinawan-Japanese centenarians and nonagenarians.

Authors:  H Takata; M Suzuki; T Ishii; S Sekiguchi; H Iri
Journal:  Lancet       Date:  1987-10-10       Impact factor: 79.321

5.  Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury.

Authors:  M H Crawford; F L Grover; W P Kolb; C A McMahan; R A O'Rourke; L M McManus; R N Pinckard
Journal:  Circulation       Date:  1988-12       Impact factor: 29.690

6.  Admission criteria for immunogerontological studies in man: the SENIEUR protocol.

Authors:  G J Ligthart; J X Corberand; C Fournier; P Galanaud; W Hijmans; B Kennes; H K Müller-Hermelink; G G Steinmann
Journal:  Mech Ageing Dev       Date:  1984-11       Impact factor: 5.432

7.  Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls.

Authors:  J Bertrams; U Hintzen; V Schlicht; S Schoeps; F A Gries; T K Louton; M P Baur
Journal:  Immunobiology       Date:  1984-05       Impact factor: 3.144

8.  [Polymorphism of C4 and factor B in type I diabetes].

Authors:  J F Blickle; G Hauptmann; J Goetz; M M Tongio; S Mayer; J M Brogard; M Dorner
Journal:  Pathol Biol (Paris)       Date:  1988-06

9.  Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.

Authors:  P R Maroko; C B Carpenter; M Chiariello; M C Fishbein; P Radvany; J D Knostman; S L Hale
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

10.  Genetic polymorphism of the fourth component of complement and type 1 (insulin-dependent) diabetes.

Authors:  A Marcelli-Barge; J C Poirier; M Schmid; I Deschamps; H Lestradet; P Prevost; J Hors
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

View more
  7 in total

1.  Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality.

Authors:  G J Arason; J Kramer; B Blaskó; R Kolka; P Thorbjornsdottir; K Einarsdóttir; A Sigfúsdóttir; S T Sigurdarson; G Sigurdsson; Z Rónai; Z Prohászka; M Sasvári-Székely; S Bödvarsson; G Thorgeirsson; G Füst
Journal:  Clin Exp Immunol       Date:  2007-04-11       Impact factor: 4.330

2.  C4B*Q0 allotype as risk factor for myocardial infarction.

Authors:  J Kramer; K Rajczy; L Hegyi; T Fülöp; A Mohácsi; Z Mezei; M Keltai; G Blaskó; E Ferenczy; N Anh-Tuan
Journal:  BMJ       Date:  1994-07-30

3.  Real-time PCR quantification of human complement C4A and C4B genes.

Authors:  Agnes Szilagyi; Bernadett Blasko; Denes Szilassy; George Fust; Maria Sasvari-Szekely; Zsolt Ronai
Journal:  BMC Genet       Date:  2006-01-10       Impact factor: 2.797

4.  Association between Age and the 7 Repeat Allele of the Dopamine D4 Receptor Gene.

Authors:  Anna Szekely; Eszter Kotyuk; Julianna Bircher; Andrea Vereczkei; David A Balota; Maria Sasvari-Szekely; Zsolt Ronai
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

5.  Investigation of complement component C4 copy number variation in human longevity.

Authors:  Friederike Flachsbart; Amke Caliebe; Femke-Anouska Heinsen; Tom Hemming-Karlsen; Stefan Schreiber; Andre Franke; Almut Nebel
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

6.  Common genetic variants of the human steroid 21-hydroxylase gene (CYP21A2) are related to differences in circulating hormone levels.

Authors:  Márton Doleschall; Julianna Anna Szabó; Júlia Pázmándi; Ágnes Szilágyi; Klára Koncz; Henriette Farkas; Miklós Tóth; Péter Igaz; Edit Gláz; Zoltán Prohászka; Márta Korbonits; Károly Rácz; George Füst; Attila Patócs
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

7.  Multiallelic copy number variation in the complement component 4A (C4A) gene is associated with late-stage age-related macular degeneration (AMD).

Authors:  Felix Grassmann; Stuart Cantsilieris; Anja-Sabrina Schulz-Kuhnt; Stefan J White; Andrea J Richardson; Alex W Hewitt; Brendan J Vote; Denise Schmied; Robyn H Guymer; Bernhard H F Weber; Paul N Baird
Journal:  J Neuroinflammation       Date:  2016-04-18       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.